STOCK TITAN

Ceribell, Inc. (CBLL): TPG-affiliated investors report 7.8% stake in Schedule 13G/A

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Ceribell, Inc. received an amended Schedule 13G/A reporting that investment entities affiliated with TPG GP A, LLC, together with James G. Coulter and Jon Winkelried, collectively report beneficial ownership of 2,975,566 shares of Ceribell common stock. These shares are held directly by The Rise Fund Clearthought, L.P., over which TPG GP A exercises indirect control. Based on 38,378,101 shares of common stock outstanding as of August 6, 2026, the reported stake represents 7.8% of Ceribell’s common stock. The reporting persons share voting and dispositive power over these shares and disclaim beneficial ownership except to the extent of any pecuniary interest.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 2,975,566 shares Common stock of Ceribell, Inc. reported by TPG GP A, LLC and others
Percent of class 7.8% Ownership percentage of Ceribell common stock based on shares outstanding
Shares outstanding 38,378,101 shares Ceribell common stock outstanding as of August 6, 2026
Shared voting power 2,975,566 shares Shares over which each reporting person has shared voting power
Shared dispositive power 2,975,566 shares Shares over which each reporting person has shared dispositive power
beneficial ownership financial
"The percentage beneficial ownership set forth in response to Item 11 above"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power financial
"Shared Voting Power 2,975,566.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
dispositive power financial
"Shared Dispositive Power 2,975,566.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Agreement of Joint Filing regulatory
"pursuant to an Agreement of Joint Filing incorporated by reference herein"
Schedule 13G regulatory
"previously filed with the Commission as Exhibit 1 to Amendment No. 4 to Schedule 13D filed"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What ownership stake in CBLL does TPG GP A, LLC report in this Schedule 13G/A?

TPG GP A, LLC and related reporting persons report beneficial ownership of 2,975,566 shares of Ceribell, Inc. (CBLL) common stock, representing 7.8% of the company’s outstanding common stock based on 38,378,101 shares outstanding as of August 6, 2026.

Who are the reporting persons in Ceribell, Inc. (CBLL)’s amended Schedule 13G/A?

The reporting persons are TPG GP A, LLC, James G. Coulter, and Jon Winkelried. They file jointly under an Agreement of Joint Filing and may be deemed to beneficially own shares held by The Rise Fund Clearthought, L.P., subject to stated disclaimers.

How many Ceribell (CBLL) shares are outstanding according to this Schedule 13G/A?

The filing states that Ceribell, Inc. had 38,378,101 shares of common stock outstanding as of August 6, 2026, as reported in its Form 10-Q filed with the Commission on August 10, 2026, which serves as the basis for the 7.8% ownership calculation.

Through which entity are the CBLL shares held for the TPG reporting group?

The 2,975,566 shares of Ceribell common stock are held directly by The Rise Fund Clearthought, L.P.. TPG GP A, LLC exercises direct or indirect control over entities that ultimately control this limited partnership, leading to deemed beneficial ownership for the reporting persons.

Do James G. Coulter and Jon Winkelried fully acknowledge beneficial ownership of CBLL shares?

The filing states that Messrs. Coulter and Winkelried may be deemed to beneficially own the Ceribell shares held by The Rise Fund Clearthought, L.P., but each disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

What voting and dispositive powers over CBLL shares are reported in this Schedule 13G/A?

Each reporting person lists 0 shares with sole voting or dispositive power and 2,975,566 shares with shared voting and shared dispositive power. This reflects joint control over how these Ceribell shares are voted and disposed of.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





15678C102

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 38,378,101 shares of Common Stock (as defined below) outstanding as of August 6, 2026, as reported on the Quarterly Report on Form 10-Q filed by Ceribell, Inc. (the "Issuer") with the Securities and Exchange Commission (the "Commission") on August 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 38,378,101 shares of Common Stock outstanding as of August 6, 2026, as reported on the Quarterly Report on Form 10-Q filed by the Issuer with the Commission on August 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 38,378,101 shares of Common Stock outstanding as of August 6, 2026, as reported on the Quarterly Report on Form 10-Q filed by the Issuer with the Commission on August 10, 2026.


SCHEDULE 13G



TPG GP A, LLC
Signature:/s/ Matthew White
Name/Title:Matthew White / Vice President
Date:08/14/2026
COULTER, JAMES G
Signature:/s/ Gerald Neugebauer
Name/Title:Gerald Neugebauer, on behalf of James G. Coulter (1)
Date:08/14/2026
WINKELRIED JON
Signature:/s/ Gerald Neugebauer
Name/Title:Gerald Neugebauer, on behalf of Jon Winkelried (2)
Date:08/14/2026

Comments accompanying signature: (1) Gerald Neugebauer is signing on behalf of Mr. Coulter pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Coulter on February 7, 2024 (SEC File No. 001-41617). (2) Gerald Neugebauer is signing on behalf of Mr. Winkelried pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Winkelried on February 7, 2024 (SEC File No. 001-41617).
Exhibit Information

Exhibit 1 Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.* _______________ * Incorporated herein by reference to the Agreement of Joint Filing by TPG Group Holdings (SBS) Advisors, Inc., TPG GP A, LLC, TPG Advisors VII, Inc., TPG Advisors VI, Inc., TPG Advisors VI-AIV, Inc., TPG Asia Advisors VI, Inc., David Bonderman, James G. Coulter, Jon Winkelried and Karl Peterson dated as of January 18, 2022, which was previously filed with the Commission as Exhibit 1 to Amendment No. 4 to Schedule 13D filed by TPG GP A, LLC, David Bonderman, James G. Coulter and Jon Winkelried on January 18, 2022 with respect to the shares of common stock of Allogene Therapeutics, Inc.